Evidence map›Paper›PMID 34336106›Full record

ArticleOxidative medicine and cellular longevity2021

The Ameliorative Effects of Arctiin and Arctigenin on the Oxidative Injury of Lung Induced by Silica via TLR-4/NLRP3/TGF-

Xueying Liu, Jian Wang, Peiyuan Dou, Xu Zhang, Xiaoku Ran, Linlin Liu, Deqiang Dou

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Immunopharmacological potential ofFrontiers in pharmacology · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Journal of virology · 2023
    Article
  13. Article
  14. Article
  15. Advances in the Use ofAntioxidants (Basel, Switzerland) · 2023
    Review
  16. Article
  17. Article
  18. Role of mitochondrial stress and the NLRP3 inflammasome in lung diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xueying LiuCollege of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian 116600, China.ORCID https://orcid.org/0000-0001-6687-6142
Jian WangDepartment of Medicinal Chemistry, Shenyang Pharmaceutical University, Shenyang 110032, China.ORCID https://orcid.org/0000-0002-9589-4056
Peiyuan DouCollege of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian 116600, China.ORCID https://orcid.org/0000-0002-4743-2260
Xu ZhangCollege of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian 116600, China.ORCID https://orcid.org/0000-0002-5212-2590
Xiaoku RanCollege of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian 116600, China.ORCID https://orcid.org/0000-0003-2950-8898
Linlin LiuCollege of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian 116600, China.ORCID https://orcid.org/0000-0002-1784-239X
Deqiang DouCollege of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian 116600, China.ORCID https://orcid.org/0000-0003-0571-3416
Liaoning University of Traditional Chinese Medicine · CNShenyang Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silicosis remains one of the most serious diseases worldwide, with no effective drug for its treatment. Our research results have indicated that arctiin and arctigenin could increase the mitochondrial membrane potential, which in turn reduces the production of reactive oxygen species (ROS), blocks the polarization of macrophages, and inhibits the differentiation of myofibroblasts to reduce oxidative stress, inflammation, and fibrosis. Further, our study revealed that arctiin and arctigenin suppressed the activation of NLRP3 inflammasome through the TLR-4/Myd88/NF-

Indexed as

AnimalsFuransGlucosidesHumansLignansNLR Family, Pyrin Domain-Containing 3 ProteinOxidative StressRatsRats, WistarSignal TransductionSilicon DioxideToll-Like Receptor 4Transforming Growth Factor betaarctigeninarctiinFuransGlucosidesLignansNLR Family, Pyrin Domain-Containing 3 ProteinSilicon DioxideToll-Like Receptor 4Transforming Growth Factor beta

Identifiers

PMID34336106
PMCPMC8313330
OpenAlexW3183872796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.